Cargando…
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
Thyroid cancer therapy is based on surgery followed by radioiodine treatment. The incorporation of radioiodine by cancer cells is mediated by sodium iodide symporter (NIS) (codified by the SLC5A5 gene), that is functional only when targeted to the cell membrane. We aimed to evaluate if NIS expressio...
Autores principales: | Tavares, Catarina, Coelho, Maria João, Eloy, Catarina, Melo, Miguel, da Rocha, Adriana Gaspar, Pestana, Ana, Batista, Rui, Ferreira, Luciana Bueno, Rios, Elisabete, Selmi-Ruby, Samia, Cavadas, Bruno, Pereira, Luísa, Sobrinho Simões, Manuel, Soares, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754505/ https://www.ncbi.nlm.nih.gov/pubmed/29298843 http://dx.doi.org/10.1530/EC-17-0302 |
Ejemplares similares
-
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression
por: Tavares, Catarina, et al.
Publicado: (2018) -
Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
por: Ferreira, Luciana Bueno, et al.
Publicado: (2016) -
OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines
por: Ferreira, Luciana B., et al.
Publicado: (2018) -
Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017) -
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
por: Celestino, Ricardo, et al.
Publicado: (2018)